Gevo, Inc. : District Court Issues Final Judgment for Gevo

          Gevo, Inc. : District Court Issues Final Judgment for Gevo

Court enters judgment that Gevo does not infringe

ENGLEWOOD, Colo. - April 11, 2013 - Gevo, Inc. (NASDAQ: GEVO) announced  today 
that the United States District Court  for the District of Delaware entered  a 
final judgment in  favor of Gevo  and against Butamax  Advanced Biofuels,  LLC 
(Butamax), a 50/50 joint venture between DuPont and BP, ending the trial court
proceedings on Butamax's  Patent Nos.  7,851,188 ('188  Patent) and  7,993,889 
('889 Patent).

"We applaud the final judgment, which allows  us to focus on being the  leader 
in  commercializing  renewable  isobutanol  and  maintaining  our  freedom  to 
operate," said  Brett  Lund,  Gevo's  executive  vice  president  and  general 
counsel. "We feel vindicated that Butamax itself admitted that Gevo does  not 
infringe when the Court's interpretation of the patent claims is applied."

In the final judgment, the Honorable Judge Sue L. Robinson held, "It is hereby
ordered and adjudged this 10th  day of April 2013  that final judgment be  and 
hereby is  entered in  favor of  Defendant Gevo,  Inc. and  against  Plaintiff 
Butamax Advance Biofuels, LLC with respect to the claims relating to '188  and 
'889 Patents."  The final  judgment resulted  from the  Court's finding  that 
certain claims of the '889 Patent were invalid, Butamax's admission that  Gevo 
does not  literally infringe  under  the Court's  construction of  the  patent 
claims, and the Court's finding that Gevo does not infringe under the doctrine
of equivalents.

"This is a huge victory for Gevo and our shareholders," noted Patrick  Gruber, 
Ph.D., Gevo's chief executive officer. "I personally want to thank Brett, his
team, and the Cooley team for all their hard work in proving that we utilize a
proprietary technology.  Defending  our  freedom  to  operate  is  critically 
important."

About Gevo

Gevo is a leading renewable chemicals and next-generation biofuels company.
Gevo's patent-protected, capital-light business model converts existing
ethanol plants into bio-refineries to make isobutanol. This versatile chemical
can be directly integrated into existing chemical and fuel products to deliver
environmental and economic benefits. Gevo started up its first commercial
isobutanol facility in Luverne, Minn., and has a marquee list of partners
including Coca-Cola, Sasol, and LANXESS, among others. Gevo is committed to a
sustainable bio-based economy that meets society's needs for plentiful food
and clean air and water. For more information, visit www.gevo.com.

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements include statements that are not
purely statements of historical fact, and can sometimes be identified by our
use of terms such as "intend," "expect," "plan," "estimate," "future,"
"strive" and similar words. These forward-looking statements are made on the
basis of the current beliefs, expectations and assumptions of the management
of Gevo and are subject to significant risks and uncertainty. Investors are
cautioned not to place undue reliance on any such forward-looking statements.
All such forward-looking statements speak only as of the date they are made,
and the company undertakes no obligation to update or revise these statements,
whether as a result of new information, future events or otherwise. Although
the company believes that the expectations reflected in these forward-looking
statements are reasonable, these statements involve many risks and
uncertainties that may cause actual results to differ materially from what may
be expressed or implied in these forward-looking statements. For a further
discussion of risks and uncertainties that could cause actual results to
differ from those expressed in these forward-looking statements, as well as
risks relating to the business of Gevo in general, see the risk disclosures in
the Annual Report on Form 10-K of Gevo for the year ended December 31, 2012
and in subsequent reports on Forms 10-Q and 8-K and other filings made with
the SEC by Gevo.

                                     ###

Media Contact:

Steve Halsey

Gibbs & Soell for Gevo

T: (212) 697-2600

shalsey@gibbs-soell.com 

Investor Contact:

Chelsea DeLong

PR & Marketing Coordinator

T: (303) 588-6306

cdelong@gevo.com

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Gevo, Inc. via Thomson Reuters ONE
HUG#1692380